PI
AGIO icon

Putnam Investments’s Agios Pharmaceuticals AGIO Stock Holding History

Putnam Investments’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-97,500
Closed -$3.16M – 889
2019
Q3 		$3.16M Buy
+97,500
New +$4.04M 0.01% 619
2018
Q1 		– Sell
-227,350
Closed -$13M – 1084
2017
Q4 		$13M Buy
227,350
+211,727
+1,355% +$13.3M 0.03% 337
2017
Q3 		$1.04M Hold
15,623
– – ﹤0.01% 905
2017
Q2 		$803K Buy
+15,623
New +$799K ﹤0.01% 929

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Putnam Investments's AGIO Position: Q4 2019 in Review

Putnam Investments sold out of Agios Pharmaceuticals (AGIO) in Q4 2019, closing a stake of 97,500 shares — an estimated $3.16M sold.

Putnam Investments first reported a position in AGIO in Q2 2017 and held it in 4 quarters. The position peaked at $13M in Q4 2017. 198 funds tracked by Wall St. Rank hold AGIO as of Q4 2019.

  • Putnam Investments reported no remaining Agios Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Putnam Investments sold 97,500 Agios Pharmaceuticals shares in Q4 2019, an estimated $3.16M.
  • Putnam Investments first reported a position in Agios Pharmaceuticals in Q2 2017 and held it in 4 quarters.
  • Putnam Investments's Agios Pharmaceuticals position peaked at $13M in Q4 2017.
  • 198 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2019.

Based on Putnam Investments's 13F filing for Q4 2019, filed 14 Feb 2020.